Results for 'genomic'
Monty Pal
The Long Game of Cancer Genomics: John Carpten, Ph.D., on Building Precision Oncology that Reaches Patients
City of Hope, Academic Research, genomics, genome mapping, TGen, Translational Genomics Research Institute, spatial biology, AI, access
In this episode of On the Edge of Breakthrough: Voices of Cancer Research, John Carpten, Ph.D., Chief Scientific Officer at City of Hope, discusses the evolution of cancer genomics—how early genome mapping enabled today’s targeted approaches and what infrastructure and equity considerations will…
Mar 23rd • 56 mins listen
Monty Pal
Unlocking the Future of Cancer Care: Precision Medicine, AI and the Patient Voice with Dr. Stacy Gray
City of Hope, Monty Pal, Stacy Gray, precision medicine, germline testing, INSPIRE program, whole body MRI, genomic, tumor board
In this episode of On the Edge of Breakthrough: Voices of Cancer Research, Stacy Gray, M.D., A.M., Director of Clinical and Scientific Strategy and Vice President of System Strategy at City of Hope, joins Monty Pal, M.D., F.A.S.C.O. in an engaging discussion of how precision medicine and AI are tran…
Feb 23rd • 43 mins listen
Monty Pal
Building the First AI Agent for Cancer Research
City of Hope, Monty Pal, Enrique Velazquez Villarreal, Latino, colorectal cancer, mentor, genomics, AI, artificial intelligence, multiomic
Dr. Enrique Velazquez Villarreal on AI, genomics, and why young Latinos are at the heart of his work to improve colorectal cancer research and care.
May 5th • 49 mins listen
Rebecca Previs
Rethinking How We Track and Treat Cancer
diagnostic, genomics, breast cancer, antibody drug conjugate, ADC, breast cancer, lung cancer, biomarker
HER2, HER3, and MRD: Drs. Previs and Green break down ASCO highlights and what they mean for the future of cancer diagnostics.
Jul 13th • 19 mins listen
Monty Pal
Three Leaders, One Vision: Principles for Transforming Cancer Care Delivery
City of Hope, Monty Pal, Walter Stadler, Alan Bryce, ASCO, national model, precision, AI, clinical trial design, dose strategy, early detection, long term survivorship
Dr. Walter Stadler & Dr. Alan Bryce share how City of Hope is building a national system for smarter research, greater access, and better cancer care.
Jun 23rd • 43 mins listen
Rebecca Previs
Why Comprehensive Testing Matters - Ken Schlosser’s Lung Cancer Story
diagnostic, biomarker, lung cancer, advocacy, precision
Biomarker testing helped Ken Schlosser live with stage IV lung cancer for over 6 years. Here's how it shaped his care plan from the start.
Jul 31st • 23 mins listen
Rebecca Previs
FFPE: The Workhorse Behind NGS Testing
biomarker, sequencing, diagnostics, translational research, precision
Exploring FFPE’s impact on precision oncology, NGS innovation, and the future of tissue stewardship in cancer care with leading Labcorp experts.
Jan 28th • 33 mins listen
The Oncology Nursing Podcast
Patient Education for Next-Generation Sequencing to Guide Cancer Therapy
Highlights From Today’s Episode “With next-generation sequencing (NGS), multiple biomarkers can be evaluated using one test. So, in cancer care, we’re learning that any given tumor may harbor a variety of variants. So, if we’re considering using in situ hybridization (ISH)…
Mar 30th • 47 mins listen